Oregon Health and Science University
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs by Stage
Trial / Program Status
Modality Mix
Indication Coverage
Program Types
Population Tags
Strong-Evidence Records
0 recordsChecked Records With Caveats
4 checked · 0 open checksAudiobook-based auditory-training app with clear speech modes, visual speech/text support, dashboard goals, and progressive listening exercises for hearing-aid and cochlear-implant users.
Oral ORC-13661 small molecule evaluated in a randomized Phase 2 dose-ranging trial to prevent or mitigate IV amikacin-associated ototoxic hearing loss in adults with nontuberculous mycobacterial disease.
Historical Phase 1 academic trial evaluating oral acamprosate/Campral versus placebo in tinnitus.
Terminated academic early Phase 1 study of oral mineralocorticoid therapy for sudden sensorineural hearing loss after incomplete recovery with standard glucocorticoid treatment.